Charleston, SC -- (SBWIRE) -- 09/11/2013 -- Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s Penny Stocks issues news updates on the following stock: ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC), Lone Pine Resources Inc (NYSE:LPR), ChemoCentryx Inc (NASDAQ:CCXI), GTx, Inc. (NASDAQ:GTXI)
ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) ended its recent business day with the loss of -0.35% and closed at the price of $2.85 after opening at $2.83. The stock traded during its last trading session with the total volume of 1,507,800 shares, as compared to its average volume of 1.42 million shares. ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, engages in developing and commercializing immune-based therapies for the treatment of brain, ovarian, and other solid tumors.
Has IMUC Found The Bottom and Ready To Move Up? Find Out Here
Lone Pine Resources Inc (NYSE:LPR) remained among the day advancers and traded with volume of 1,505,357 shares in the last session, as compared to average volume of 2.32 million shares. In comparison with 52 week range of $0.09 - $1.86, it faced lowest price of $0.10 during the last trading session whereas its day highest price was $0.11. The company’s total market capitalization is $9.24 million, along with 86.85 million shares outstanding. Lone Pine Resources Inc. engages in the exploration and development of natural gas and light oil properties in Canada.
Can LPR Show a Strong Recovery? Find out in This Research Report
ChemoCentryx Inc (NASDAQ:CCXI) showed 1,505,200 shares in volume during the last trading session, while the average trading volume remained 337,450 shares. The stock kicked off its trading session at $6.61 and closed at $6.25 after declining -24.33%. ChemoCentryx, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders, and cancer in the United States.
Why Should Investors Buy CCXI After the Recent Fall? Just Go Here and Find Out
GTx, Inc. (NASDAQ:GTXI) stock traded during its last trading session with the total traded volume of 1,504,700 shares versus its average volume of 1.81 million shares. The company opened its trade at the price of $1.53 and its closing price was $1.59 after gaining +5.30% for the day. GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions.
Why Should Investors Buy GTXI After The Recent Gain? Just Go Here and Find Out
About Today’s Penny Stocks
Today’s Penny Stocks wants you, the investor, to have the ability to be informed in your trading decisions. Our website is designed to take you to the information you need to be at the top of your game in trading penny stocks. Today’s wants you to do your own due diligence on your investments please use our site to find the information you need on whichever investment you choose.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the TodaysPennyStocks.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
TodaysPennyStocks.com is owned and operated by FlipVentures LLC. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Read Full Disclaimer at: http://todayspennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)